FOLH1 and neoplasm: A dynamic PET scan (0–90 min after injection) revealed fast background clearance kinetics (blood and muscle) with no indication of unwanted tracer retention as well as steadily increasing tracer accumulation in PSMA-expressing tissues (tumor, kidney) over time.